Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -439.95% is 129% below its 5-year average of -192.54%, near the low end of its 5-year range (-439.95%–-28.46%).
36.44% below its 12-month average of -322.44%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -95.34%.
RETURN ON ASSETS (ROA)
-439.95%
RETURN ON ASSETS (ROA) AVG TTM
-322.44%
RETURN ON ASSETS (ROA) AVG 3Y
-242.34%
RETURN ON ASSETS (ROA) AVG 5Y
-192.54%
RETURN ON ASSETS (ROA) AVG 10Y
-294.58%
RETURN ON ASSETS (ROA) AVG 15Y
-245.59%
RETURN ON ASSETS (ROA) AVG 20Y
-214.13%
CURRENT VS TTM AVG
-36.44%
CURRENT VS 3Y AVG
-81.55%
CURRENT VS 5Y AVG
-128.50%
CURRENT VS 10Y AVG
-49.35%
CURRENT VS 15Y AVG
-79.14%
CURRENT VS 20Y AVG
-105.46%
SECTOR MEDIAN · HEALTHCARE
-30.47%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
-1343.88%
vs the sector median at left
GeoVax Labs, Inc.
Market Cap
$2.33M
Return on Assets (ROA)
-439.95%
TTM Avg
-322.44%
3Y Avg
-242.34%
5Y Avg
-192.54%
Market Cap
$2.33M
Return on Assets (ROA)
-64.42%
TTM Avg
-79.57%
3Y Avg
-65.34%
5Y Avg
-858.61%
Market Cap
$2.33M
Return on Assets (ROA)
-62.07%
TTM Avg
-132.28%
3Y Avg
-89.58%
5Y Avg
-83.72%
Market Cap
$2.48M
Return on Assets (ROA)
-143.82%
TTM Avg
-140.13%
3Y Avg
-102.17%
5Y Avg
-81.19%
Market Cap
$2.52M
Return on Assets (ROA)
-107.18%
TTM Avg
-105.74%
3Y Avg
-98.21%
5Y Avg
-95.08%
Market Cap
$2.58M
Return on Assets (ROA)
-199.30%
TTM Avg
-137.41%
3Y Avg
-109.57%
5Y Avg
-977.62%
Market Cap
$2.58M
Return on Assets (ROA)
-228.77%
TTM Avg
-130.86%
3Y Avg
-126.84%
5Y Avg
-140.90%
Market Cap
$2.62M
Return on Assets (ROA)
-121.85%
TTM Avg
-199.78%
3Y Avg
-166.32%
5Y Avg
-134.78%
Market Cap
$1.95M
Return on Assets (ROA)
-404.67%
TTM Avg
-168.15%
3Y Avg
-182.58%
5Y Avg
-275.93%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | $2.33M | -439.95% | -322.44% | -242.34% | -192.54% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | -64.42% | -79.57% | -65.34% | -858.61% |
| Onconetix, Inc. (ONCO)vs › | $2.33M | -62.07% | -132.28% | -89.58% | -83.72% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.48M | -143.82% | -140.13% | -102.17% | -81.19% |
| Jaguar Health, Inc. (JAGX)vs › | $2.52M | -107.18% | -105.74% | -98.21% | -95.08% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.58M | -199.30% | -137.41% | -109.57% | -977.62% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.58M | -228.77% | -130.86% | -126.84% | -140.90% |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -121.85% | -199.78% | -166.32% | -134.78% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.95M | -404.67% | -168.15% | -182.58% | -275.93% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -154.47% | -121.84% | -88.87% | -75.91% |
ROA
-439.9%
ROE
-1160.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -338.46% |
| 2024-12-31 | -306.43% |
| 2023-12-31 | -279.72% |
| 2022-12-31 | -44.73% |
| 2021-12-31 | -157.42% |
| 2020-12-31 | -28.46% |
| 2019-12-31 | -505.59% |
| 2018-12-31 | -398.75% |
| 2017-12-31 | -442.68% |
| 2016-12-31 | -536.15% |
| 2015-12-31 | -201.96% |
| 2014-12-31 | -205.04% |
| 2013-12-31 | -80.47% |
| 2012-12-31 | -144.45% |
| 2011-12-31 | -142.65% |
| 2010-12-31 | -116.52% |
| 2009-12-31 | -76.10% |
| 2008-12-31 | -121.99% |
| 2007-12-31 | -130.66% |
| 2006-12-31 | -24.38% |
| 2005-12-31 | -1797.03% |
| 2004-12-31 | -11522.39% |
| 2003-12-31 | -1786.95% |
| 2002-12-31 | -166.60% |
| 2001-12-31 | -338.29% |
| 2000-12-31 | -79.00% |
| 1999-12-31 | -275.98% |
| 1998-12-31 | -91.25% |
| 1997-12-31 | -54.86% |
| 1996-12-31 | 1077.58% |
